IFP Advisors’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

IFP Advisors’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,200	Closed	-$860	–	5266
2026 Q1	$860	Buy	4,200 +4,000	+2,000%	+$18.2K	﹤0.01%	4268
2025 Q4	$1.12K	Hold	200	–	–	﹤0.01%	4038
2025 Q3	$1.47K	Hold	200	–	–	﹤0.01%	3805
2025 Q2	$1.52K	Sell	200 -45	-18%	-$701	﹤0.01%	4021
2025 Q1	$4.67K	Hold	245	–	–	﹤0.01%	2866
2024 Q4	$8.87K	Buy	+245	New	+$6.82K	﹤0.01%	2569

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

IFP Advisors's RVPH Position: Q2 2026 in Review

IFP Advisors sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 4,200 shares — an estimated $860 sold.

IFP Advisors first reported a position in RVPH in Q4 2024 and held it in 6 quarters. The position peaked at $8.87K in Q4 2024. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

IFP Advisors reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
IFP Advisors sold 4,200 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $860.
IFP Advisors first reported a position in REVIVA PHARMA HLDGS INC in Q4 2024 and held it in 6 quarters.
IFP Advisors's REVIVA PHARMA HLDGS INC position peaked at $8.87K in Q4 2024.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.